News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Michael Serzan: Join a conversation The ASCO Post with Wenxin Xu and I as we dissect recent data to guide therapy!
Photo taken from Michael Serzan/Twitter.
Sep 26, 2023, 18:38

Michael Serzan: Join a conversation The ASCO Post with Wenxin Xu and I as we dissect recent data to guide therapy!

Quoting Michael Serzan, Genitourinary Medical Oncologist at the Dana Farber Cancer Institute, on X/Twitter:

“Few areas of oncology are as hot as Kidney Cancer in 2023! Join a conversation The ASCO Post with Wenxin Xu and I as we dissect recent data to guide therapy! Combination Therapies for Advanced RCC: Making Sense of Recent Data.”

For more information click here.
Source: Michael Serzan/Twitter.

ASCO Post cancer kidney cancer Michael Serzan OncoDaily Oncology Wenxin Xu
Special Coverage
Blog
Jan 19, 2025, 05:34
New Bench to Bedside Chats from Project Catalyst’s initiative - FDA Oncology
Blog
Jan 19, 2025, 05:31
Michael White on what makes MD Anderson Cancer Center special
Insight
Jan 19, 2025, 04:47
Loay Kassem: If your patient can't afford a CDK4/6 inhibitor, don't settle down for endocrine therapy alone
Insight
Jan 19, 2025, 04:45
Enrique Grande: Adjuvant Radiation Following Cystectomy
Insight
Jan 19, 2025, 04:13
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer
Blog
Jan 19, 2025, 03:06
Yvonne Diaz: AI, wearables and digital tech in clinical research
Societies
Jan 18, 2025, 23:03
Abstract submission system open for the ESMO Gynaecological Cancers 2025
Science
Jan 18, 2025, 23:00
New training modules on pain management in cancer care - Society for Integrative Oncology
Blog
Jan 18, 2025, 22:58
Wafik S. El-Deiry: Honored to express a vision for the field of cancer research and innovation in oncology
Blog
Jan 18, 2025, 22:56
Herbert Loong: Philip Ip kicked off the 12th Hong Kong pathology forum
Insight
Jan 18, 2025, 22:55
Last days to apply for the ‘Improving Cancer Outcomes and Leadership’ course - ESO
Drugs
Jan 18, 2025, 22:55
Jean-Charles Soria: FDA approved 57 new therapeutic drugs in 2024